FDA approves the Flexichamber collapsible valved holding chamber

FSC Laboratories has announced that its Flexichamber collapsible valved holding chamber has received FDA clearance for use with most pMDIs. The device, which can be used with or without a mask, will be available by prescription only and will be distributed by FSC Pediatrics.

FSC Pediatrics President and CEO Peter W. Steelman commented, “We developed Flexichamber, a patented, compact collapsible holding chamber, to address pediatric patient and parent needs by combining the clinical effectiveness expected from the leading hard-sided chambers and the convenience of a device that can easily fit in a pocket, backpack, or purse.”

Read the FSC Laboratories press release.

Share

published on

December 9-December 11: DDL 2026, Edinburgh, Scotland

April 27-30: RDD Europe 2027, Antibes, France

June 30: RespireX 2027, Boston, MA, USA